Ocular Therapeutixâ„¢ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZAâ„¢
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring